Table 4. The clinicopathological features of SEO-EC patients with favorable prognosis.
| Characteristics | Adjuvant therapy | |
|---|---|---|
| No | Yes | |
| Number of patients | 10 | 13 |
| Follow-up period (mon) | 59 (33–138) | 66 (8–202) |
| Recurrence | 0 (0) | 2 (15) |
| Death | 0 (0) | 1 (7.7) |
| Myometrial invasion (≥1/2) | 0 (0) | 4 (31) |
| Endometrial pathological grade (G3) | 0 (0) | 2 (15) |
| LVSI of endometrial lesions (yes) | 2 (20) | 4 (31) |
| Ovary (bilateral) | 3 (30) | 2 (15) |
| Ovarian pathological grade (G3) | 0 (0) | 1 (7.7) |
| Fallopian tubal involvement (yes) | 2 (20) | 3 (23) |
| Peritoneal cytology (positive) | 2 (20) | 5 (39) |
Values are presented as number of patients (%) of median (range).
LVSI, lymphovascular space invasion; SEO-EC, synchronous endometrial and ovarian endometrioid cancer.